drugset / Trial / NCT00411125
Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women
RandomizedCrossoverDouble-blindTreatment
Summary
This is a phase I study to analyze bioavailability and pharmacodynamic of two different variants of oral salmon calcitonin (SMC021) in postmenopausal women
Timeline
- Start
- 2006-08
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | salmon calcitonin | Unknown | 0.8 mg | Oral |